Embla Medical hf.
OSSFFOTCHealthcare● Active
$5.11
+$0.96(+23.13%)
Market Cap$2.2B
P/E Ratio—
52W High$5.325
52W Low$4.15
Embla Medical hf. (OSSFF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OSSFF · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.09B | $0.11B | $0.09B | $0.06B | $0.10B |
| Depreciation & Amort. | $0.06B | $0.06B | $0.05B | $0.05B | $0.05B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.01B) | ($0.01B) | ($0.01B) | ($0.02B) | ($0.02B) |
| Net Cash from Operations | $0.14B | $0.12B | $0.09B | $0.06B | $0.10B |
| Investing Activities | |||||
| Capital Expenditure | ($0.02B) | ($0.04B) | ($0.04B) | ($0.03B) | ($0.03B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.06B) | ($0.10B) | ($0.06B) | ($0.07B) | ($0.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.01B) | $0.00B | $0.00B | ($0.01B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.03B) | $0.04B | ($0.01B) | $0.04B | ($0.03B) |
| Net Cash from Financing | ($0.07B) | $0.01B | ($0.04B) | $0.00B | ($0.05B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.12B | $0.08B | $0.05B | $0.03B | $0.07B |
| FCF Margin %(computed) | 12.34% | 8.99% | 6.62% | 4.85% | 10.27% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Embla Medical hf. data
About Embla Medical hf. (OSSFF) Cash Flow Statement
Embla Medical hf. generated operating cash flow of $0.14B and free cash flow of $0.12B for 2025 — a FCF margin of 12.34%. Capital expenditure was ($0.02B).
Frequently asked questions
OSSFF · 4 questionsEmbla Medical hf. generated free cash flow of $0.12B for 2025, up 54.8% year-over-year.
OSSFF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10